Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

1.3K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

1.2K
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
1.2K
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

90
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
90
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

2.1K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
2.1K
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

45
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

2.8K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validity of Continuous Glucose Monitoring for the Diagnosis of Dumping Syndrome After Metabolic Surgery, in Comparison to the Oral Glucose Tolerance Test.

Obesity surgeryยท2024
Same author

FORUM Position Paper The Growing Global Wildland Urban Interface (WUI) Fire Dilemma: Priority Needs for Research.

Fire safety journalยท2019
Same author

Medical therapy in patients with endogenous hypoglycaemia: Is euglycaemia achievable?

Clinical endocrinologyยท2019
Same author

Impact of Carbohydrate Content and Glycemic Load on Postprandial Glucose After Roux-en-Y Gastric Bypass.

Obesity surgeryยท2015
Same author

Usefulness of acarbose and dietary modifications to limit glycemic variability following Roux-en-Y gastric bypass as assessed by continuous glucose monitoring.

Diabetes technology & therapeuticsยท2012
Same author

High glycemic variability assessed by continuous glucose monitoring after surgical treatment of obesity by gastric bypass.

Diabetes technology & therapeuticsยท2011

Related Experiment Video

Updated: Apr 29, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K

[External insulin pump treatment].

Nelly Puech-Bret, Eric Guillaume

    Soins; La Revue De Reference Infirmiere
    |May 21, 2014
    PubMed
    Summary
    This summary is machine-generated.

    External insulin pumps, a key part of intensified insulin therapy, offer a major advance for diabetes management. Technological progress in pumps and glucose sensors has significantly improved their use and effectiveness over the past decade.

    More Related Videos

    Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
    08:32

    Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

    Published on: January 4, 2018

    11.7K
    Intra-Omental Islet Transplantation Using h-Omental Matrix Islet filliNG hOMING
    07:36

    Intra-Omental Islet Transplantation Using h-Omental Matrix Islet filliNG hOMING

    Published on: March 14, 2019

    8.4K

    Related Experiment Videos

    Last Updated: Apr 29, 2026

    Improving IV Insulin Administration in a Community Hospital
    12:08

    Improving IV Insulin Administration in a Community Hospital

    Published on: June 11, 2012

    19.7K
    Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
    08:32

    Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

    Published on: January 4, 2018

    11.7K
    Intra-Omental Islet Transplantation Using h-Omental Matrix Islet filliNG hOMING
    07:36

    Intra-Omental Islet Transplantation Using h-Omental Matrix Islet filliNG hOMING

    Published on: March 14, 2019

    8.4K

    Area of Science:

    • Endocrinology and Metabolism
    • Medical Devices and Technology

    Context:

    • External insulin pumps are integral to intensified insulin therapy for diabetes management.
    • Widespread adoption has increased since French health insurance coverage began in 2000.
    • Significant technological advancements in infusion equipment and glucose sensors have occurred over the last decade.

    Purpose:

    • To highlight the role and evolution of external insulin pumps in diabetes treatment.
    • To underscore the impact of technological progress on insulin pump therapy.

    Summary:

    • External insulin pumps represent a significant advancement in intensified insulin therapy.
    • Their use has grown substantially, supported by technological innovations in both pumps and continuous glucose monitoring systems.
    • Recent technological progress has been crucial in enhancing the efficacy and adoption of these devices.

    Impact:

    • Improved diabetes management through advanced therapeutic options.
    • Enhanced patient quality of life via more effective insulin delivery systems.
    • Demonstrates the critical role of technological innovation in chronic disease treatment.